---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-106817"
form_type: "8-K"
ticker: "TNYA"
cik: "0001858848"
company_name: "Tenaya Therapeutics, Inc."
filed_at: "2024-09-16T23:59:59+00:00"
generated_at: "2026-05-31T04:42:32.351978+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Tenaya Therapeutics adopts 2024 Inducement Plan, reclassifies director to balance board

## Summary
- Karah Parschauer reclassified from Class I to Class II director to balance board classes (3 per class).
- Board reduced size to 9 directors; Parschauer's compensation unchanged, remains on Audit Committee.
- Adopted 2024 Inducement Equity Incentive Plan, reserving 1,200,000 shares for new-hire inducement awards.
- Plan intended as material inducement for new employees; no shareholder approval required under Nasdaq rules.

## SEC filing metadata
- accession: 0000950170-24-106817
- form_type: 8-K
- ticker: TNYA
- cik: 0001858848
- company_name: Tenaya Therapeutics, Inc.
- filed_at: 2024-09-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1858848/000095017024106817/0000950170-24-106817-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1858848/000095017024106817/tnya-20240912.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-106817
- JSON: https://secwatch.observer/filing/0000950170-24-106817.json
- Plain text: https://secwatch.observer/filing/0000950170-24-106817.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.